{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:50:44Z","timestamp":1784289044054,"version":"3.55.0"},"reference-count":34,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2022.2553","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T11:12:04Z","timestamp":1654081924000},"source":"Crossref","is-referenced-by-count":7,"title":["Pembrolizumab\u2011induced aseptic meningitis in a patient with non\u2011small cell lung cancer: A case report and literature review of aseptic meningitis as an immune\u2011related adverse event"],"prefix":"10.3892","volume":"17","author":[{"given":"Genki","family":"Inui","sequence":"first","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Funaki","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Makino","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Touge","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Yonago Medical Center, Yonago, Tottori 683\u20110006, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Nonaka","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamane","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Teruya","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Sueda","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kodani","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kawase","sequence":"additional","affiliation":[{"name":"Department of Brain and Neurosciences, Division of Neurology, and 4Department of Pathology, Division of Pathology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Umekita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Pathology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Horie","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Pathology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanae","family":"Nosaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Pathology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"key20220624110048_b1-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.6004\/jnccn.2019.0059","article-title":"NCCN guidelines insights: Non-small cell lung cancer, version 1.2020","volume":"17","author":"Ettinger","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"1756286418799864","key":"key20220624110048_b2-MCO-0-0-02553","doi-asserted-by":"publisher","DOI":"10.1177\/1756286418799864","article-title":"Neurological complications of immune checkpoint inhibitors: What happens when you \u2018take the brakes off\u2019 the immune system","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"key20220624110048_b3-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"key20220624110048_b4-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"key":"key20220624110048_b5-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N Engl J Med"},{"key":"key20220624110048_b6-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"key":"key20220624110048_b7-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"key20220624110048_b8-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jtho.2018.10.003","article-title":"Third-line nivolumab monotherapy in recurrent SCLC: CheckMate 032","volume":"14","author":"Ready","year":"2019","journal-title":"J Thorac Oncol"},{"key":"key20220624110048_b9-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"key20220624110048_b10-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.clineuro.2010.06.003","article-title":"Accuracy of physical signs for detecting meningitis: A hospital-based diagnostic accuracy study","volume":"112","author":"Waghdhare","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"key20220624110048_b11-MCO-0-0-02553","doi-asserted-by":"crossref","first-page":"39","DOI":"10.29245\/2572.942X\/2016\/4.1040","article-title":"Central nervous system toxicities of anti-cancer immune checkpoint blockade","volume":"1","author":"Blackmon","year":"2016","journal-title":"J Neurol Neuromedicine"},{"key":"key20220624110048_b12-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.2169\/internalmedicine.2537-18","article-title":"Elevated adenosine deaminase levels in the cerebrospinal fluid in immune checkpoint inhibitor-induced autoimmune encephalitis","volume":"58","author":"Fujiwara","year":"2019","journal-title":"Intern Med"},{"key":"key20220624110048_b13-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3109\/00365540903428158","article-title":"Adenosine deaminase and tuberculous meningitis-a systematic review with meta-analysis","volume":"42","author":"Tuon","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"key20220624110048_b14-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5692\/clinicalneurol.cn-001218","article-title":"A case of meningoencephalitis associated with pembrolizumab treated for squamous cell lung cancer","volume":"59","author":"Yonenobu","year":"2019","journal-title":"Rinsho Shinkeigaku"},{"key":"key20220624110048_b15-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1474-4422(05)01013-6","article-title":"Tuberculous meningitis: Many questions, too few answers","volume":"4","author":"Thwaites","year":"2005","journal-title":"Lancet Neurol"},{"key":"key20220624110048_b16-MCO-0-0-02553","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/ncn3.158","article-title":"Importance of the quotient of albumin, quotient of immunoglobulin G and Reibergram in inflammatory neurological disorders with disease-specific patterns of blood-brain barrier permeability","volume":"3","author":"Akaishi","year":"2015","journal-title":"Neurol Clin Neurosci"},{"issue":"108","key":"key20220624110048_b17-MCO-0-0-02553","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00108","article-title":"Fatal necrotizing encephalopathy after treatment with nivolumab for squamous non-small cell lung cancer: Case report and review of the literature","volume":"9","author":"Leitinger","year":"2018","journal-title":"Front Immunol"},{"key":"key20220624110048_b18-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/(sici)1097-0142(19980215)82:4<733::aid-cncr17>3.0.co;2-z","article-title":"Cerebrospinal fluid cytology in patients with cancer: Minimizing false-negative results","volume":"82","author":"Glantz","year":"1998","journal-title":"Cancer"},{"key":"key20220624110048_b19-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/annonc\/mdw558","article-title":"Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: A single centre experience and review of the literature","volume":"28","author":"Spain","year":"2017","journal-title":"Ann Oncol"},{"key":"key20220624110048_b20-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/practneurol-2012-000447","article-title":"Neurological immune-related adverse events of ipilimumab","volume":"13","author":"Bot","year":"2013","journal-title":"Pract Neurol"},{"issue":"e53745","key":"key20220624110048_b21-MCO-0-0-02553","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053745","article-title":"The price of tumor control: An analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network","volume":"8","author":"Voskens","year":"2013","journal-title":"PLoS One"},{"key":"key20220624110048_b22-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s10637-011-9787-1","article-title":"Severe meningo-radiculo-neuritis associated with ipilimumab","volume":"30","author":"Bompaire","year":"2012","journal-title":"Invest New Drugs"},{"key":"key20220624110048_b23-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/CJI.0b013e318156e47e","article-title":"Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis","volume":"30","author":"Yang","year":"2007","journal-title":"J Immunother"},{"key":"key20220624110048_b24-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3892\/mco.2019.1929","article-title":"Relapse of aseptic meningitis induced by ipilimumab and nivolumab therapy for metastatic renal cell carcinoma: A case report","volume":"11","author":"Takamatsu","year":"2019","journal-title":"Mol Clin Oncol"},{"key":"key20220624110048_b25-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ccr3.2534","article-title":"Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature","volume":"8","author":"Cordes","year":"2019","journal-title":"Clin Case Rep"},{"issue":"100012","key":"key20220624110048_b26-MCO-0-0-02553","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2020.100012","article-title":"Atezolizumab-induced aseptic meningitis in patients with NSCLC","volume":"1","author":"Toyozawa","year":"2020","journal-title":"JTO Clin Res Rep"},{"issue":"7183747","key":"key20220624110048_b27-MCO-0-0-02553","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7183747","article-title":"Aseptic meningitis as an immune-related adverse event after pembrolizumab","volume":"2019","author":"Lima","year":"2019","journal-title":"Case Rep Oncol Med"},{"key":"key20220624110048_b28-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2177\/jsci.40.102","article-title":"Immune-related adverse events of immune checkpoint inhibitors","volume":"40","author":"Tadano","year":"2017","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"key20220624110048_b29-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1200\/JCO.2015.60.8448","article-title":"Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at memorial sloan kettering cancer center","volume":"33","author":"Horvat","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20220624110048_b30-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"issue":"e439","key":"key20220624110048_b31-MCO-0-0-02553","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000439","article-title":"Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis","volume":"5","author":"Hottinger","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"key20220624110048_b32-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.jtho.2017.08.022","article-title":"Early immune-related adverse events and association with outcome in advanced non-small cell lung cancer patients treated with nivolumab: A prospective cohort study","volume":"12","author":"Teraoka","year":"2017","journal-title":"J Thorac Oncol"},{"key":"key20220624110048_b33-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3892\/mco.2018.1777","article-title":"Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report","volume":"10","author":"Niki","year":"2019","journal-title":"Mol Clin Oncol"},{"key":"key20220624110048_b34-MCO-0-0-02553","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/jamaoncol.2019.1022","article-title":"Evaluation of readministration of immune checkpoint inhibitors after immune-related adverse events in patients with cancer","volume":"5","author":"Simonaggio","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T08:00:58Z","timestamp":1656057658000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2022.2553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2022.2553","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"article-number":"120"}}